News

Medical Device Network on MSN2d
Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) ...
BioWorld2d
Abbott studies show CGM users have fewer hospitalizations
A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces ...
pharmaphorum3d
Why non-diabetics using CGM may not be a good idea
A new randomised clinical trial – carried out by researchers at the University of Bath in the UK – found that a CGM sold by Abbott (the Freestyle Libre 2) "systemically overestimated" glucose ...
Drug Delivery Business3d
Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.
Hosted on MSN1mon
Glooko integrates Abbott’s FreeStyle Libre onto platform
Abbott’s continuous glucose monitoring (CGM) device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management. The integration is available for ...
pharmaphorum9d
Real-time Abbott glucose monitor available to NHS after UK launch
Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...